about
Role of Nrf2 in bone metabolismThe role of "bone immunological niche" for a new pathogenetic paradigm of osteoporosisOsteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implicationsPotential role for therapies targeting DKK1, LRP5, and serotonin in the treatment of osteoporosisUsing GWAS to identify novel therapeutic targets for osteoporosis.Modeling and remodeling effects of intermittent administration of teriparatide (parathyroid hormone 1-34) on bone morphogenetic protein-induced bone in a rat spinal fusion model.Genetic and transcriptional control of bone formationBisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.Conditional inactivation of noggin in the postnatal skeleton causes osteopeniaOsteoblast lineage-specific effects of notch activation in the skeletonOsteoporosis: now and the futureInterplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism.LRP5 and bone mass regulation: Where are we now?Dickkopf-1 is regulated by the mevalonate pathway in breast cancer.Glucocorticoid-induced osteoporosis and parathyroid hormone.Diagnosis and treatment of osteopenia.The regulation of valvular and vascular sclerosis by osteogenic morphogensOsteoporosis in older persons: current pharmacotherapy and future directions.The IOC consensus statement: beyond the Female Athlete Triad--Relative Energy Deficiency in Sport (RED-S).BMP-2 Enhances Lgr4 Gene Expression in Osteoblastic Cells.Short Anabolic Peptides for Bone Growth.Gorham-Stout Disease: a Clinical Case Report and Immunological Mechanisms in Bone Erosion.The effects of direct inhibition of geranylgeranyl pyrophosphate synthase on osteoblast differentiation.Soluble activin type IIB receptor improves fracture healing in a closed tibial fracture mouse model.Parathyroid hormone inhibits Notch signaling in osteoblasts and osteocytes.Trabecular bone microstructure and local gene expression in iliac crest biopsies of men with idiopathic osteoporosis.MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosis.Rosmarinic acid exerts an antiosteoporotic effect in the RANKL-induced mouse model of bone loss by promotion of osteoblastic differentiation and inhibition of osteoclastic differentiation.
P2860
Q26778148-30C9860E-E70A-40D4-9F46-34FB0DB9E2A6Q26780523-A944D83B-9EA4-43FB-832C-EDD66F9B8C7EQ26824690-C35678A6-8E73-4BC2-B8D3-2E8CB405FAB1Q28256427-D1D81CA2-8207-4B90-A7F4-809400995ED9Q30275429-E5BCB2F6-C996-459C-9137-66005FA33CEAQ33716899-2821563D-2D0D-4AAF-86BB-3501BDD060A9Q34073161-0CD24C40-B22C-47E7-B6EF-7C2046980526Q34440107-F992AC74-D904-4966-B937-090E601D8D15Q34496410-7012110B-CA2F-4447-B1F7-703345095FEDQ34765802-E59EE782-DD8B-4926-B31E-663E9AEC95F4Q35872773-80B4CA86-A855-4217-B88A-53ADE65ACCE2Q36542861-61D99AF1-F330-4F08-BD3B-A571E059203EQ36564425-8E5F47B8-9B76-48EB-8C75-F90C88D4FFA7Q36600824-3D5D4F6A-16DD-4A87-8506-99AE0B3FB749Q36995895-CAC47A18-3CBC-4545-8E37-34FC4134D8B7Q37690947-E91E21DF-7EC5-4FFF-909C-A687A2124688Q37799488-0E046E4C-4ABB-4A88-876A-9DBCC0534D8EQ37828472-A3D9F4B6-6D50-49A4-A39F-70958CDAAEEAQ37919693-7A959360-19A1-4CCD-89CA-22B032FA08F7Q38124052-EF2D013D-762D-420B-BA67-4B1E6C11082CQ38195277-ECBA7891-3D79-4E7E-86EA-534820254895Q38838558-AE70F3BA-ED98-4068-9295-F26D33E8CA7BQ38864194-1EED36F5-1D4D-4F2E-B3F0-3CF8F9A1EB99Q39048390-F171137E-9507-4AA0-9C3C-12E74227D8F7Q39556401-E375EFC2-8A4B-4C2A-BA38-9BCBF72D3813Q41008310-795AA2FA-F958-462D-9BCC-A4AFD6031751Q42511931-7985517D-E5B0-41DF-B80F-910B7177957DQ43989185-329548F9-4A00-42AC-92F4-13953D9FDC8FQ47428797-37AF3756-9A1F-42BE-A900-2E9C3130F9FEQ54310881-E06C2376-67E3-42B5-AB0A-24ECEA85BC99
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Update in new anabolic therapies for osteoporosis
@ast
Update in new anabolic therapies for osteoporosis
@en
type
label
Update in new anabolic therapies for osteoporosis
@ast
Update in new anabolic therapies for osteoporosis
@en
prefLabel
Update in new anabolic therapies for osteoporosis
@ast
Update in new anabolic therapies for osteoporosis
@en
P2860
P356
P1476
Update in new anabolic therapies for osteoporosis
@en
P2093
Ernesto Canalis
P2860
P304
P356
10.1210/JC.2009-2677
P407
P577
2010-04-01T00:00:00Z